Jeffrey Sherman made an insider purchase in NeoGenomics on August 8, 2025, signaling confidence in the company's prospects.
1 report, 1 independent
Updated Aug 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Jeffrey Sherman made an insider purchase in NeoGenomics on August 8, 2025, signaling confidence in the company's prospects.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Jeffrey Sherman
Social Psychologist and Professor of Psychology at the University of California, Davis.
Nothing else this week.
-
NeoGenomics
cancer genetics diagnostic testing company based in Fort Myers, Florida, USA
Nothing else this week.
Coverage
Newest first; wire copies grouped- StockStoryWhy NeoGenomics (NEO) Stock Is Trading Up Today Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) jumped 4.8% in the afternoon session after news of a significant insider purch